[Cite as http://purl.org/au-research/grants/nhmrc/1150144]
Prof Jamie Craig
A/Pr Alex Hewitt
A/Pr Stuart Macgregor
Prof David Mackey
Brief description Glaucoma is the leading cause of irreversible blindness worldwide. By 2020, it will affect 80 million people, and in Australia over the next decade, the overall cost of glaucoma will reach $4.3 billion per annum. This Program will use genetic advances to personalise treatment. Blindness will be prevented in individuals at highest risk, new ways to treat patients will be developed, and better outcomes for patients will result from less treatment and monitoring of low risk cases.
Funding Amount $AUD 9,466,000.00
Funding Scheme Program Grants